Feed 2617.HK
26
TransThera Sciences (Nanjing). Inc.
2617.HK · HKSE
$10.38 -2.63% (-$0.28)
1M +7.38%
Market Cap ¥3.6B
P/E Ratio -
Div. Yield -
ROE -
Valuation
0 /100
Expensive P/B 8.65x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 30.43%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROIC 71.81%
ROA 54.22%
Debt
72 /100
Low Int. coverage -2,444.98x
Debt/Equity 0.00x
Net debt/EBITDA 1.42x
Stability
7 /100
Unstable Profitable years 0
Beta 3.27x
EPS volatility 68.35%
Ask StockBot about 2617.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Yong Qian Wu
Employees
123
Headquarters
Nanjing